Global Gene Therapy-based Drug Market Research Report 2023
Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
According to QYResearch’s new survey, global Gene Therapy-based Drug market is projected to reach US$ 34850 million in 2029, increasing from US$ 9063 million in 2022, with the CAGR of 20.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Gene Therapy-based Drug market research.
The advanced therapy based on gene market is driven by the potential to revolutionize healthcare by offering personalized and targeted treatments for genetic disorders and other diseases. Advanced therapy based on gene includes gene therapy, cell therapy, and gene editing techniques, which aim to modify or replace faulty genes to treat or cure diseases at the genetic level. The rise in the understanding of genetic mechanisms and advancements in biotechnology and genetic engineering contribute to market growth as these therapies hold promise for previously untreatable conditions. Moreover, increasing investment in research and clinical trials and the support from regulatory agencies for accelerated approval further boost the development and commercialization of advanced gene therapies. However, the market also faces challenges, including the complexity of manufacturing and delivering gene-based therapies, safety concerns related to viral vectors and off-target effects in gene editing, and high treatment costs. Additionally, addressing regulatory requirements and ensuring accessibility and affordability of advanced gene therapies can pose obstacles for broader adoption. To succeed, companies must focus on research and development to advance the safety and efficacy of gene-based therapies, collaborate with healthcare stakeholders to build robust infrastructure, and address the challenges to fully realize the transformative potential of advanced therapy based on gene in modern medicine.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Gene Therapy-based Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
According to QYResearch’s new survey, global Gene Therapy-based Drug market is projected to reach US$ 34850 million in 2029, increasing from US$ 9063 million in 2022, with the CAGR of 20.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Gene Therapy-based Drug market research.
The advanced therapy based on gene market is driven by the potential to revolutionize healthcare by offering personalized and targeted treatments for genetic disorders and other diseases. Advanced therapy based on gene includes gene therapy, cell therapy, and gene editing techniques, which aim to modify or replace faulty genes to treat or cure diseases at the genetic level. The rise in the understanding of genetic mechanisms and advancements in biotechnology and genetic engineering contribute to market growth as these therapies hold promise for previously untreatable conditions. Moreover, increasing investment in research and clinical trials and the support from regulatory agencies for accelerated approval further boost the development and commercialization of advanced gene therapies. However, the market also faces challenges, including the complexity of manufacturing and delivering gene-based therapies, safety concerns related to viral vectors and off-target effects in gene editing, and high treatment costs. Additionally, addressing regulatory requirements and ensuring accessibility and affordability of advanced gene therapies can pose obstacles for broader adoption. To succeed, companies must focus on research and development to advance the safety and efficacy of gene-based therapies, collaborate with healthcare stakeholders to build robust infrastructure, and address the challenges to fully realize the transformative potential of advanced therapy based on gene in modern medicine.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Gene Therapy-based Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Biogen
- Novartis
- Gilead Sciences
- Sarepta Therapeutics
- Alnylam Pharmaceuticals
- Amgen
- Spark Therapeutics
- Akcea Therapeutics
- bluebird bio
- Sunway Biotech
- SIBIONO
- AnGes
- Orchard Therapeutics
- Human Stem Cells Institute
- Viral Gene Delivery System
- Non-viral Gene Delivery System
- Neurological Diseases
- Cancer
- Other
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy-based Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Viral Gene Delivery System
1.2.3 Non-viral Gene Delivery System
1.3 Market by Application
1.3.1 Global Gene Therapy-based Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Gene Therapy-based Drug Market Perspective (2018-2029)
2.2 Gene Therapy-based Drug Growth Trends by Region
2.2.1 Global Gene Therapy-based Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Gene Therapy-based Drug Historic Market Size by Region (2018-2023)
2.2.3 Gene Therapy-based Drug Forecasted Market Size by Region (2024-2029)
2.3 Gene Therapy-based Drug Market Dynamics
2.3.1 Gene Therapy-based Drug Industry Trends
2.3.2 Gene Therapy-based Drug Market Drivers
2.3.3 Gene Therapy-based Drug Market Challenges
2.3.4 Gene Therapy-based Drug Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Gene Therapy-based Drug Players by Revenue
3.1.1 Global Top Gene Therapy-based Drug Players by Revenue (2018-2023)
3.1.2 Global Gene Therapy-based Drug Revenue Market Share by Players (2018-2023)
3.2 Global Gene Therapy-based Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Therapy-based Drug Revenue
3.4 Global Gene Therapy-based Drug Market Concentration Ratio
3.4.1 Global Gene Therapy-based Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy-based Drug Revenue in 2022
3.5 Gene Therapy-based Drug Key Players Head office and Area Served
3.6 Key Players Gene Therapy-based Drug Product Solution and Service
3.7 Date of Enter into Gene Therapy-based Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 GENE THERAPY-BASED DRUG BREAKDOWN DATA BY TYPE
4.1 Global Gene Therapy-based Drug Historic Market Size by Type (2018-2023)
4.2 Global Gene Therapy-based Drug Forecasted Market Size by Type (2024-2029)
5 GENE THERAPY-BASED DRUG BREAKDOWN DATA BY APPLICATION
5.1 Global Gene Therapy-based Drug Historic Market Size by Application (2018-2023)
5.2 Global Gene Therapy-based Drug Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Gene Therapy-based Drug Market Size (2018-2029)
6.2 North America Gene Therapy-based Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Gene Therapy-based Drug Market Size by Country (2018-2023)
6.4 North America Gene Therapy-based Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Gene Therapy-based Drug Market Size (2018-2029)
7.2 Europe Gene Therapy-based Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Gene Therapy-based Drug Market Size by Country (2018-2023)
7.4 Europe Gene Therapy-based Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Gene Therapy-based Drug Market Size (2018-2029)
8.2 Asia-Pacific Gene Therapy-based Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Gene Therapy-based Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Gene Therapy-based Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Gene Therapy-based Drug Market Size (2018-2029)
9.2 Latin America Gene Therapy-based Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Gene Therapy-based Drug Market Size by Country (2018-2023)
9.4 Latin America Gene Therapy-based Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Gene Therapy-based Drug Market Size (2018-2029)
10.2 Middle East & Africa Gene Therapy-based Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Gene Therapy-based Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Gene Therapy-based Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Biogen
11.1.1 Biogen Company Detail
11.1.2 Biogen Business Overview
11.1.3 Biogen Gene Therapy-based Drug Introduction
11.1.4 Biogen Revenue in Gene Therapy-based Drug Business (2018-2023)
11.1.5 Biogen Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Gene Therapy-based Drug Introduction
11.2.4 Novartis Revenue in Gene Therapy-based Drug Business (2018-2023)
11.2.5 Novartis Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Detail
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Gene Therapy-based Drug Introduction
11.3.4 Gilead Sciences Revenue in Gene Therapy-based Drug Business (2018-2023)
11.3.5 Gilead Sciences Recent Development
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Detail
11.4.2 Sarepta Therapeutics Business Overview
11.4.3 Sarepta Therapeutics Gene Therapy-based Drug Introduction
11.4.4 Sarepta Therapeutics Revenue in Gene Therapy-based Drug Business (2018-2023)
11.4.5 Sarepta Therapeutics Recent Development
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Detail
11.5.2 Alnylam Pharmaceuticals Business Overview
11.5.3 Alnylam Pharmaceuticals Gene Therapy-based Drug Introduction
11.5.4 Alnylam Pharmaceuticals Revenue in Gene Therapy-based Drug Business (2018-2023)
11.5.5 Alnylam Pharmaceuticals Recent Development
11.6 Amgen
11.6.1 Amgen Company Detail
11.6.2 Amgen Business Overview
11.6.3 Amgen Gene Therapy-based Drug Introduction
11.6.4 Amgen Revenue in Gene Therapy-based Drug Business (2018-2023)
11.6.5 Amgen Recent Development
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Detail
11.7.2 Spark Therapeutics Business Overview
11.7.3 Spark Therapeutics Gene Therapy-based Drug Introduction
11.7.4 Spark Therapeutics Revenue in Gene Therapy-based Drug Business (2018-2023)
11.7.5 Spark Therapeutics Recent Development
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Detail
11.8.2 Akcea Therapeutics Business Overview
11.8.3 Akcea Therapeutics Gene Therapy-based Drug Introduction
11.8.4 Akcea Therapeutics Revenue in Gene Therapy-based Drug Business (2018-2023)
11.8.5 Akcea Therapeutics Recent Development
11.9 bluebird bio
11.9.1 bluebird bio Company Detail
11.9.2 bluebird bio Business Overview
11.9.3 bluebird bio Gene Therapy-based Drug Introduction
11.9.4 bluebird bio Revenue in Gene Therapy-based Drug Business (2018-2023)
11.9.5 bluebird bio Recent Development
11.10 Sunway Biotech
11.10.1 Sunway Biotech Company Detail
11.10.2 Sunway Biotech Business Overview
11.10.3 Sunway Biotech Gene Therapy-based Drug Introduction
11.10.4 Sunway Biotech Revenue in Gene Therapy-based Drug Business (2018-2023)
11.10.5 Sunway Biotech Recent Development
11.11 SIBIONO
11.11.1 SIBIONO Company Detail
11.11.2 SIBIONO Business Overview
11.11.3 SIBIONO Gene Therapy-based Drug Introduction
11.11.4 SIBIONO Revenue in Gene Therapy-based Drug Business (2018-2023)
11.11.5 SIBIONO Recent Development
11.12 AnGes
11.12.1 AnGes Company Detail
11.12.2 AnGes Business Overview
11.12.3 AnGes Gene Therapy-based Drug Introduction
11.12.4 AnGes Revenue in Gene Therapy-based Drug Business (2018-2023)
11.12.5 AnGes Recent Development
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Detail
11.13.2 Orchard Therapeutics Business Overview
11.13.3 Orchard Therapeutics Gene Therapy-based Drug Introduction
11.13.4 Orchard Therapeutics Revenue in Gene Therapy-based Drug Business (2018-2023)
11.13.5 Orchard Therapeutics Recent Development
11.14 Human Stem Cells Institute
11.14.1 Human Stem Cells Institute Company Detail
11.14.2 Human Stem Cells Institute Business Overview
11.14.3 Human Stem Cells Institute Gene Therapy-based Drug Introduction
11.14.4 Human Stem Cells Institute Revenue in Gene Therapy-based Drug Business (2018-2023)
11.14.5 Human Stem Cells Institute Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy-based Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Viral Gene Delivery System
1.2.3 Non-viral Gene Delivery System
1.3 Market by Application
1.3.1 Global Gene Therapy-based Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Gene Therapy-based Drug Market Perspective (2018-2029)
2.2 Gene Therapy-based Drug Growth Trends by Region
2.2.1 Global Gene Therapy-based Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Gene Therapy-based Drug Historic Market Size by Region (2018-2023)
2.2.3 Gene Therapy-based Drug Forecasted Market Size by Region (2024-2029)
2.3 Gene Therapy-based Drug Market Dynamics
2.3.1 Gene Therapy-based Drug Industry Trends
2.3.2 Gene Therapy-based Drug Market Drivers
2.3.3 Gene Therapy-based Drug Market Challenges
2.3.4 Gene Therapy-based Drug Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Gene Therapy-based Drug Players by Revenue
3.1.1 Global Top Gene Therapy-based Drug Players by Revenue (2018-2023)
3.1.2 Global Gene Therapy-based Drug Revenue Market Share by Players (2018-2023)
3.2 Global Gene Therapy-based Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Therapy-based Drug Revenue
3.4 Global Gene Therapy-based Drug Market Concentration Ratio
3.4.1 Global Gene Therapy-based Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy-based Drug Revenue in 2022
3.5 Gene Therapy-based Drug Key Players Head office and Area Served
3.6 Key Players Gene Therapy-based Drug Product Solution and Service
3.7 Date of Enter into Gene Therapy-based Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 GENE THERAPY-BASED DRUG BREAKDOWN DATA BY TYPE
4.1 Global Gene Therapy-based Drug Historic Market Size by Type (2018-2023)
4.2 Global Gene Therapy-based Drug Forecasted Market Size by Type (2024-2029)
5 GENE THERAPY-BASED DRUG BREAKDOWN DATA BY APPLICATION
5.1 Global Gene Therapy-based Drug Historic Market Size by Application (2018-2023)
5.2 Global Gene Therapy-based Drug Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Gene Therapy-based Drug Market Size (2018-2029)
6.2 North America Gene Therapy-based Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Gene Therapy-based Drug Market Size by Country (2018-2023)
6.4 North America Gene Therapy-based Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Gene Therapy-based Drug Market Size (2018-2029)
7.2 Europe Gene Therapy-based Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Gene Therapy-based Drug Market Size by Country (2018-2023)
7.4 Europe Gene Therapy-based Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Gene Therapy-based Drug Market Size (2018-2029)
8.2 Asia-Pacific Gene Therapy-based Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Gene Therapy-based Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Gene Therapy-based Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Gene Therapy-based Drug Market Size (2018-2029)
9.2 Latin America Gene Therapy-based Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Gene Therapy-based Drug Market Size by Country (2018-2023)
9.4 Latin America Gene Therapy-based Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Gene Therapy-based Drug Market Size (2018-2029)
10.2 Middle East & Africa Gene Therapy-based Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Gene Therapy-based Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Gene Therapy-based Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Biogen
11.1.1 Biogen Company Detail
11.1.2 Biogen Business Overview
11.1.3 Biogen Gene Therapy-based Drug Introduction
11.1.4 Biogen Revenue in Gene Therapy-based Drug Business (2018-2023)
11.1.5 Biogen Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Gene Therapy-based Drug Introduction
11.2.4 Novartis Revenue in Gene Therapy-based Drug Business (2018-2023)
11.2.5 Novartis Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Detail
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Gene Therapy-based Drug Introduction
11.3.4 Gilead Sciences Revenue in Gene Therapy-based Drug Business (2018-2023)
11.3.5 Gilead Sciences Recent Development
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Detail
11.4.2 Sarepta Therapeutics Business Overview
11.4.3 Sarepta Therapeutics Gene Therapy-based Drug Introduction
11.4.4 Sarepta Therapeutics Revenue in Gene Therapy-based Drug Business (2018-2023)
11.4.5 Sarepta Therapeutics Recent Development
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Detail
11.5.2 Alnylam Pharmaceuticals Business Overview
11.5.3 Alnylam Pharmaceuticals Gene Therapy-based Drug Introduction
11.5.4 Alnylam Pharmaceuticals Revenue in Gene Therapy-based Drug Business (2018-2023)
11.5.5 Alnylam Pharmaceuticals Recent Development
11.6 Amgen
11.6.1 Amgen Company Detail
11.6.2 Amgen Business Overview
11.6.3 Amgen Gene Therapy-based Drug Introduction
11.6.4 Amgen Revenue in Gene Therapy-based Drug Business (2018-2023)
11.6.5 Amgen Recent Development
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Detail
11.7.2 Spark Therapeutics Business Overview
11.7.3 Spark Therapeutics Gene Therapy-based Drug Introduction
11.7.4 Spark Therapeutics Revenue in Gene Therapy-based Drug Business (2018-2023)
11.7.5 Spark Therapeutics Recent Development
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Detail
11.8.2 Akcea Therapeutics Business Overview
11.8.3 Akcea Therapeutics Gene Therapy-based Drug Introduction
11.8.4 Akcea Therapeutics Revenue in Gene Therapy-based Drug Business (2018-2023)
11.8.5 Akcea Therapeutics Recent Development
11.9 bluebird bio
11.9.1 bluebird bio Company Detail
11.9.2 bluebird bio Business Overview
11.9.3 bluebird bio Gene Therapy-based Drug Introduction
11.9.4 bluebird bio Revenue in Gene Therapy-based Drug Business (2018-2023)
11.9.5 bluebird bio Recent Development
11.10 Sunway Biotech
11.10.1 Sunway Biotech Company Detail
11.10.2 Sunway Biotech Business Overview
11.10.3 Sunway Biotech Gene Therapy-based Drug Introduction
11.10.4 Sunway Biotech Revenue in Gene Therapy-based Drug Business (2018-2023)
11.10.5 Sunway Biotech Recent Development
11.11 SIBIONO
11.11.1 SIBIONO Company Detail
11.11.2 SIBIONO Business Overview
11.11.3 SIBIONO Gene Therapy-based Drug Introduction
11.11.4 SIBIONO Revenue in Gene Therapy-based Drug Business (2018-2023)
11.11.5 SIBIONO Recent Development
11.12 AnGes
11.12.1 AnGes Company Detail
11.12.2 AnGes Business Overview
11.12.3 AnGes Gene Therapy-based Drug Introduction
11.12.4 AnGes Revenue in Gene Therapy-based Drug Business (2018-2023)
11.12.5 AnGes Recent Development
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Detail
11.13.2 Orchard Therapeutics Business Overview
11.13.3 Orchard Therapeutics Gene Therapy-based Drug Introduction
11.13.4 Orchard Therapeutics Revenue in Gene Therapy-based Drug Business (2018-2023)
11.13.5 Orchard Therapeutics Recent Development
11.14 Human Stem Cells Institute
11.14.1 Human Stem Cells Institute Company Detail
11.14.2 Human Stem Cells Institute Business Overview
11.14.3 Human Stem Cells Institute Gene Therapy-based Drug Introduction
11.14.4 Human Stem Cells Institute Revenue in Gene Therapy-based Drug Business (2018-2023)
11.14.5 Human Stem Cells Institute Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Gene Therapy-based Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Viral Gene Delivery System
Table 3. Key Players of Non-viral Gene Delivery System
Table 4. Global Gene Therapy-based Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Gene Therapy-based Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Gene Therapy-based Drug Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Gene Therapy-based Drug Market Share by Region (2018-2023)
Table 8. Global Gene Therapy-based Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Gene Therapy-based Drug Market Share by Region (2024-2029)
Table 10. Gene Therapy-based Drug Market Trends
Table 11. Gene Therapy-based Drug Market Drivers
Table 12. Gene Therapy-based Drug Market Challenges
Table 13. Gene Therapy-based Drug Market Restraints
Table 14. Global Gene Therapy-based Drug Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Gene Therapy-based Drug Market Share by Players (2018-2023)
Table 16. Global Top Gene Therapy-based Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy-based Drug as of 2022)
Table 17. Ranking of Global Top Gene Therapy-based Drug Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Gene Therapy-based Drug Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Gene Therapy-based Drug Product Solution and Service
Table 21. Date of Enter into Gene Therapy-based Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gene Therapy-based Drug Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Gene Therapy-based Drug Revenue Market Share by Type (2018-2023)
Table 25. Global Gene Therapy-based Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Gene Therapy-based Drug Revenue Market Share by Type (2024-2029)
Table 27. Global Gene Therapy-based Drug Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Gene Therapy-based Drug Revenue Market Share by Application (2018-2023)
Table 29. Global Gene Therapy-based Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Gene Therapy-based Drug Revenue Market Share by Application (2024-2029)
Table 31. North America Gene Therapy-based Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Gene Therapy-based Drug Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Gene Therapy-based Drug Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Gene Therapy-based Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Gene Therapy-based Drug Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Gene Therapy-based Drug Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Gene Therapy-based Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Gene Therapy-based Drug Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Gene Therapy-based Drug Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Gene Therapy-based Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Gene Therapy-based Drug Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Gene Therapy-based Drug Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Gene Therapy-based Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Gene Therapy-based Drug Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Gene Therapy-based Drug Market Size by Country (2024-2029) & (US$ Million)
Table 46. Biogen Company Detail
Table 47. Biogen Business Overview
Table 48. Biogen Gene Therapy-based Drug Product
Table 49. Biogen Revenue in Gene Therapy-based Drug Business (2018-2023) & (US$ Million)
Table 50. Biogen Recent Development
Table 51. Novartis Company Detail
Table 52. Novartis Business Overview
Table 53. Novartis Gene Therapy-based Drug Product
Table 54. Novartis Revenue in Gene Therapy-based Drug Business (2018-2023) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Gilead Sciences Company Detail
Table 57. Gilead Sciences Business Overview
Table 58. Gilead Sciences Gene Therapy-based Drug Product
Table 59. Gilead Sciences Revenue in Gene Therapy-based Drug Business (2018-2023) & (US$ Million)
Table 60. Gilead Sciences Recent Development
Table 61. Sarepta Therapeutics Company Detail
Table 62. Sarepta Therapeutics Business Overview
Table 63. Sarepta Therapeutics Gene Therapy-based Drug Product
Table 64. Sarepta Therapeutics Revenue in Gene Therapy-based Drug Business (2018-2023) & (US$ Million)
Table 65. Sarepta Therapeutics Recent Development
Table 66. Alnylam Pharmaceuticals Company Detail
Table 67. Alnylam Pharmaceuticals Business Overview
Table 68. Alnylam Pharmaceuticals Gene Therapy-based Drug Product
Table 69. Alnylam Pharmaceuticals Revenue in Gene Therapy-based Drug Business (2018-2023) & (US$ Million)
Table 70. Alnylam Pharmaceuticals Recent Development
Table 71. Amgen Company Detail
Table 72. Amgen Business Overview
Table 73. Amgen Gene Therapy-based Drug Product
Table 74. Amgen Revenue in Gene Therapy-based Drug Business (2018-2023) & (US$ Million)
Table 75. Amgen Recent Development
Table 76. Spark Therapeutics Company Detail
Table 77. Spark Therapeutics Business Overview
Table 78. Spark Therapeutics Gene Therapy-based Drug Product
Table 79. Spark Therapeutics Revenue in Gene Therapy-based Drug Business (2018-2023) & (US$ Million)
Table 80. Spark Therapeutics Recent Development
Table 81. Akcea Therapeutics Company Detail
Table 82. Akcea Therapeutics Business Overview
Table 83. Akcea Therapeutics Gene Therapy-based Drug Product
Table 84. Akcea Therapeutics Revenue in Gene Therapy-based Drug Business (2018-2023) & (US$ Million)
Table 85. Akcea Therapeutics Recent Development
Table 86. bluebird bio Company Detail
Table 87. bluebird bio Business Overview
Table 88. bluebird bio Gene Therapy-based Drug Product
Table 89. bluebird bio Revenue in Gene Therapy-based Drug Business (2018-2023) & (US$ Million)
Table 90. bluebird bio Recent Development
Table 91. Sunway Biotech Company Detail
Table 92. Sunway Biotech Business Overview
Table 93. Sunway Biotech Gene Therapy-based Drug Product
Table 94. Sunway Biotech Revenue in Gene Therapy-based Drug Business (2018-2023) & (US$ Million)
Table 95. Sunway Biotech Recent Development
Table 96. SIBIONO Company Detail
Table 97. SIBIONO Business Overview
Table 98. SIBIONO Gene Therapy-based Drug Product
Table 99. SIBIONO Revenue in Gene Therapy-based Drug Business (2018-2023) & (US$ Million)
Table 100. SIBIONO Recent Development
Table 101. AnGes Company Detail
Table 102. AnGes Business Overview
Table 103. AnGes Gene Therapy-based Drug Product
Table 104. AnGes Revenue in Gene Therapy-based Drug Business (2018-2023) & (US$ Million)
Table 105. AnGes Recent Development
Table 106. Orchard Therapeutics Company Detail
Table 107. Orchard Therapeutics Business Overview
Table 108. Orchard Therapeutics Gene Therapy-based Drug Product
Table 109. Orchard Therapeutics Revenue in Gene Therapy-based Drug Business (2018-2023) & (US$ Million)
Table 110. Orchard Therapeutics Recent Development
Table 111. Human Stem Cells Institute Company Detail
Table 112. Human Stem Cells Institute Business Overview
Table 113. Human Stem Cells Institute Gene Therapy-based Drug Product
Table 114. Human Stem Cells Institute Revenue in Gene Therapy-based Drug Business (2018-2023) & (US$ Million)
Table 115. Human Stem Cells Institute Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 1. Global Gene Therapy-based Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Viral Gene Delivery System
Table 3. Key Players of Non-viral Gene Delivery System
Table 4. Global Gene Therapy-based Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Gene Therapy-based Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Gene Therapy-based Drug Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Gene Therapy-based Drug Market Share by Region (2018-2023)
Table 8. Global Gene Therapy-based Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Gene Therapy-based Drug Market Share by Region (2024-2029)
Table 10. Gene Therapy-based Drug Market Trends
Table 11. Gene Therapy-based Drug Market Drivers
Table 12. Gene Therapy-based Drug Market Challenges
Table 13. Gene Therapy-based Drug Market Restraints
Table 14. Global Gene Therapy-based Drug Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Gene Therapy-based Drug Market Share by Players (2018-2023)
Table 16. Global Top Gene Therapy-based Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy-based Drug as of 2022)
Table 17. Ranking of Global Top Gene Therapy-based Drug Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Gene Therapy-based Drug Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Gene Therapy-based Drug Product Solution and Service
Table 21. Date of Enter into Gene Therapy-based Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gene Therapy-based Drug Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Gene Therapy-based Drug Revenue Market Share by Type (2018-2023)
Table 25. Global Gene Therapy-based Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Gene Therapy-based Drug Revenue Market Share by Type (2024-2029)
Table 27. Global Gene Therapy-based Drug Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Gene Therapy-based Drug Revenue Market Share by Application (2018-2023)
Table 29. Global Gene Therapy-based Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Gene Therapy-based Drug Revenue Market Share by Application (2024-2029)
Table 31. North America Gene Therapy-based Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Gene Therapy-based Drug Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Gene Therapy-based Drug Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Gene Therapy-based Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Gene Therapy-based Drug Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Gene Therapy-based Drug Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Gene Therapy-based Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Gene Therapy-based Drug Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Gene Therapy-based Drug Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Gene Therapy-based Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Gene Therapy-based Drug Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Gene Therapy-based Drug Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Gene Therapy-based Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Gene Therapy-based Drug Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Gene Therapy-based Drug Market Size by Country (2024-2029) & (US$ Million)
Table 46. Biogen Company Detail
Table 47. Biogen Business Overview
Table 48. Biogen Gene Therapy-based Drug Product
Table 49. Biogen Revenue in Gene Therapy-based Drug Business (2018-2023) & (US$ Million)
Table 50. Biogen Recent Development
Table 51. Novartis Company Detail
Table 52. Novartis Business Overview
Table 53. Novartis Gene Therapy-based Drug Product
Table 54. Novartis Revenue in Gene Therapy-based Drug Business (2018-2023) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Gilead Sciences Company Detail
Table 57. Gilead Sciences Business Overview
Table 58. Gilead Sciences Gene Therapy-based Drug Product
Table 59. Gilead Sciences Revenue in Gene Therapy-based Drug Business (2018-2023) & (US$ Million)
Table 60. Gilead Sciences Recent Development
Table 61. Sarepta Therapeutics Company Detail
Table 62. Sarepta Therapeutics Business Overview
Table 63. Sarepta Therapeutics Gene Therapy-based Drug Product
Table 64. Sarepta Therapeutics Revenue in Gene Therapy-based Drug Business (2018-2023) & (US$ Million)
Table 65. Sarepta Therapeutics Recent Development
Table 66. Alnylam Pharmaceuticals Company Detail
Table 67. Alnylam Pharmaceuticals Business Overview
Table 68. Alnylam Pharmaceuticals Gene Therapy-based Drug Product
Table 69. Alnylam Pharmaceuticals Revenue in Gene Therapy-based Drug Business (2018-2023) & (US$ Million)
Table 70. Alnylam Pharmaceuticals Recent Development
Table 71. Amgen Company Detail
Table 72. Amgen Business Overview
Table 73. Amgen Gene Therapy-based Drug Product
Table 74. Amgen Revenue in Gene Therapy-based Drug Business (2018-2023) & (US$ Million)
Table 75. Amgen Recent Development
Table 76. Spark Therapeutics Company Detail
Table 77. Spark Therapeutics Business Overview
Table 78. Spark Therapeutics Gene Therapy-based Drug Product
Table 79. Spark Therapeutics Revenue in Gene Therapy-based Drug Business (2018-2023) & (US$ Million)
Table 80. Spark Therapeutics Recent Development
Table 81. Akcea Therapeutics Company Detail
Table 82. Akcea Therapeutics Business Overview
Table 83. Akcea Therapeutics Gene Therapy-based Drug Product
Table 84. Akcea Therapeutics Revenue in Gene Therapy-based Drug Business (2018-2023) & (US$ Million)
Table 85. Akcea Therapeutics Recent Development
Table 86. bluebird bio Company Detail
Table 87. bluebird bio Business Overview
Table 88. bluebird bio Gene Therapy-based Drug Product
Table 89. bluebird bio Revenue in Gene Therapy-based Drug Business (2018-2023) & (US$ Million)
Table 90. bluebird bio Recent Development
Table 91. Sunway Biotech Company Detail
Table 92. Sunway Biotech Business Overview
Table 93. Sunway Biotech Gene Therapy-based Drug Product
Table 94. Sunway Biotech Revenue in Gene Therapy-based Drug Business (2018-2023) & (US$ Million)
Table 95. Sunway Biotech Recent Development
Table 96. SIBIONO Company Detail
Table 97. SIBIONO Business Overview
Table 98. SIBIONO Gene Therapy-based Drug Product
Table 99. SIBIONO Revenue in Gene Therapy-based Drug Business (2018-2023) & (US$ Million)
Table 100. SIBIONO Recent Development
Table 101. AnGes Company Detail
Table 102. AnGes Business Overview
Table 103. AnGes Gene Therapy-based Drug Product
Table 104. AnGes Revenue in Gene Therapy-based Drug Business (2018-2023) & (US$ Million)
Table 105. AnGes Recent Development
Table 106. Orchard Therapeutics Company Detail
Table 107. Orchard Therapeutics Business Overview
Table 108. Orchard Therapeutics Gene Therapy-based Drug Product
Table 109. Orchard Therapeutics Revenue in Gene Therapy-based Drug Business (2018-2023) & (US$ Million)
Table 110. Orchard Therapeutics Recent Development
Table 111. Human Stem Cells Institute Company Detail
Table 112. Human Stem Cells Institute Business Overview
Table 113. Human Stem Cells Institute Gene Therapy-based Drug Product
Table 114. Human Stem Cells Institute Revenue in Gene Therapy-based Drug Business (2018-2023) & (US$ Million)
Table 115. Human Stem Cells Institute Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Gene Therapy-based Drug Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Gene Therapy-based Drug Market Share by Type: 2022 VS 2029
Figure 3. Viral Gene Delivery System Features
Figure 4. Non-viral Gene Delivery System Features
Figure 5. Global Gene Therapy-based Drug Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Gene Therapy-based Drug Market Share by Application: 2022 VS 2029
Figure 7. Neurological Diseases Case Studies
Figure 8. Cancer Case Studies
Figure 9. Other Case Studies
Figure 10. Gene Therapy-based Drug Report Years Considered
Figure 11. Global Gene Therapy-based Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Gene Therapy-based Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Gene Therapy-based Drug Market Share by Region: 2022 VS 2029
Figure 14. Global Gene Therapy-based Drug Market Share by Players in 2022
Figure 15. Global Top Gene Therapy-based Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy-based Drug as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Gene Therapy-based Drug Revenue in 2022
Figure 17. North America Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Gene Therapy-based Drug Market Share by Country (2018-2029)
Figure 19. United States Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Gene Therapy-based Drug Market Share by Country (2018-2029)
Figure 23. Germany Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Gene Therapy-based Drug Market Share by Region (2018-2029)
Figure 31. China Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Gene Therapy-based Drug Market Share by Country (2018-2029)
Figure 39. Mexico Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Gene Therapy-based Drug Market Share by Country (2018-2029)
Figure 43. Turkey Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Biogen Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2023)
Figure 46. Novartis Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2023)
Figure 47. Gilead Sciences Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2023)
Figure 48. Sarepta Therapeutics Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2023)
Figure 49. Alnylam Pharmaceuticals Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2023)
Figure 50. Amgen Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2023)
Figure 51. Spark Therapeutics Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2023)
Figure 52. Akcea Therapeutics Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2023)
Figure 53. bluebird bio Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2023)
Figure 54. Sunway Biotech Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2023)
Figure 55. SIBIONO Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2023)
Figure 56. AnGes Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2023)
Figure 57. Orchard Therapeutics Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2023)
Figure 58. Human Stem Cells Institute Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Figure 1. Global Gene Therapy-based Drug Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Gene Therapy-based Drug Market Share by Type: 2022 VS 2029
Figure 3. Viral Gene Delivery System Features
Figure 4. Non-viral Gene Delivery System Features
Figure 5. Global Gene Therapy-based Drug Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Gene Therapy-based Drug Market Share by Application: 2022 VS 2029
Figure 7. Neurological Diseases Case Studies
Figure 8. Cancer Case Studies
Figure 9. Other Case Studies
Figure 10. Gene Therapy-based Drug Report Years Considered
Figure 11. Global Gene Therapy-based Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Gene Therapy-based Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Gene Therapy-based Drug Market Share by Region: 2022 VS 2029
Figure 14. Global Gene Therapy-based Drug Market Share by Players in 2022
Figure 15. Global Top Gene Therapy-based Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy-based Drug as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Gene Therapy-based Drug Revenue in 2022
Figure 17. North America Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Gene Therapy-based Drug Market Share by Country (2018-2029)
Figure 19. United States Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Gene Therapy-based Drug Market Share by Country (2018-2029)
Figure 23. Germany Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Gene Therapy-based Drug Market Share by Region (2018-2029)
Figure 31. China Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Gene Therapy-based Drug Market Share by Country (2018-2029)
Figure 39. Mexico Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Gene Therapy-based Drug Market Share by Country (2018-2029)
Figure 43. Turkey Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Biogen Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2023)
Figure 46. Novartis Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2023)
Figure 47. Gilead Sciences Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2023)
Figure 48. Sarepta Therapeutics Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2023)
Figure 49. Alnylam Pharmaceuticals Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2023)
Figure 50. Amgen Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2023)
Figure 51. Spark Therapeutics Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2023)
Figure 52. Akcea Therapeutics Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2023)
Figure 53. bluebird bio Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2023)
Figure 54. Sunway Biotech Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2023)
Figure 55. SIBIONO Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2023)
Figure 56. AnGes Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2023)
Figure 57. Orchard Therapeutics Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2023)
Figure 58. Human Stem Cells Institute Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
